These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-000235-28||The effects of a single evening dose of 3mg eszopiclone on next day driving ability and psychomotor/memory function in patients with primary insomnia compared to placebo||not-yet-due|
|Completed, but no date||2004-003661-33||A Pilot Study of the Safety and Efficacy of SEP-226330 in Subjects with Restless Legs Syndrome||bad-data|
|Listed as ongoing, but also has a completion date||2006-001529-24||Adults administered Venlafaxine and Eszopiclone Response to Treatment (AVERT): A 31-Week, Efficacy, Safety and Tolerability Study of Eszopiclone 3 mg Co-administered with Venlafaxine in Subjects with ...||2009-07-30||bad-data|
|Reported results||2010-019000-22||Long-Term Eslicarbazepine Acetate Extension Study||2017-04-25||due-trials|